Medical Weight Loss Program

Take back control of your overall health and wellness with a once-weekly injection

Compounded semaglutide
$350/month

Compounded tirzepatide  programs are currently on hold due to FDA regulations

We are working with compounded tirzepatide patients to bridge with compounded semaglutide until new compounded medications become available (anticipated around 5/2025)

100% virtual (telehealth) program
Self-inject once a week a home
Step-by-step guidance for medication administration
Virtual follow ups with our nurse practitioner
Unlimited access via text for symptom management
Tailored program for your medical needs, budget, and tolerance
Individualized program for weaning to avoid regaining weight

What to Expect
Our compounded peptides are a tool to help you use weight in addition to healthy lifestyle modification.  Compounded peptides help to slow down your GI tract which helps you feel fuller for longer and reduce the signaling of your "hungry hormone" to your brain, helping you eat less to achieve a calorie deficit, ultimately producing weight loss.  

It is important to maintain adequate protein and water intake while on this medication. The most commonly reported side effects are nausea, early satiety, indigestion, and constipation. Most people can lose up to 15-20% of their total body weight with compounded peptides along with diet and exercise modification.

Clients should commit to a minimum of 2-3 months. Some people elect to use this medication for up to a year or more, depending on their BMI and weight loss goals. 

Eligibility Criteria
BMI 27+ with high blood pressure or high cholesterol (diabetic clients will not be approved) or BMI 30+ and otherwise healthy
Ability/willingness to self-inject once weekly (teaching provided)
Access to technology for virtual exams/follow up
Access to a scale
Blood work available for review within the last year
Established with a primary care provider

Applicants with personal or family history of Multiple Endocrine Neoplasia type 2 or medullary thyroid cancer will not be permitted